Corporate
Description
  • Value proposition

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

    Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

  • Original language

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

  • Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

    Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

  • https://www.kurmapartners.com/en
Entity interactions BETA
Entity TypeTweets Articles
Sygnature Discovery Sygnature Discovery
biotech, deeptech, Biotechnology Research
Capitalistic
Partnership
Not event

21 Nov 2017


Radars
Loading...